INFLUENCE OF DRUG LEVELS DURING THE FIRST ANTI-TNF THERAPY ON THE CLINICAL RESPONSE TO A SECOND BIOLOGIC IN RHEUMATOID ARTHRITIS PATIENTS

被引：0
|
作者：
Plasencia-Rodriguez, C. [1 ]
Pascual-Salcedo, M. D. [2 ]
Bonilla, G. [1 ]
Navarro-Compan, V. [1 ]
Martinez-Feito, A. [2 ]
Diego, C. [2 ]
Villalba, A. [1 ]
Peiteado, D. [1 ]
Nuno, L. [1 ]
Martin-Mola, E. [1 ]
Balsa, A. [1 ]
机构：
[1] La Paz Univ Hosp Idipaz, Rheumatol, Madrid, Spain
[2] La Paz Univ Hosp Idipaz, Immunol, Madrid, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷
关键词：
D O I：
10.1136/annrheumdis-2016-eular.5036
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0305
引用
收藏
页码：1004 / 1004
页数：1
相关论文
共 50 条
  • [21] Influence of age on the outcome of anti-TNFα therapy in rheumatoid arthritis
    Radovits, Beata J.
    Kievit, Wietske
    Fransen, Jaap
    van de Laar, Mart A. F. J.
    Jansen, Tim L.
    van Riel, Piet L. C. M.
    Laan, Roland F. J. M.
    ARTHRITIS AND RHEUMATISM, 2008, 58 (09): : S765 - S765
  • [22] Biomarkers for prognosis of response to anti-TNF therapy of rheumatoid arthritis
    Stuhlmueller, B.
    Skriner, K.
    Haeupl, T.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2015, 74 (09): : 812 - +
  • [23] Adherence to therapy of etanercept and infliximab during first anti-TNF treament course in rheumatoid arthritis patients
    Kristensen, L
    Geborek, P
    Saxne, T
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 431 - 431
  • [24] Cutaneous manifestations during anti-TNF therapy in rheumatoid arthritis
    Solau-Gervais, E
    Lebas, D
    Duquesnoy, B
    Delaporte, E
    Flipo, R
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 458 - 458
  • [25] First pegylated anti-TNF for rheumatoid arthritis
    Siddall, Rhonda
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2008, 69 (09) : 496 - 496
  • [26] CHANGES OF METABOLIC BIOMARKER LEVELS UPON ANTI-TNF THERAPY IN RHEUMATOID ARTHRITIS PATIENTS
    Bodnar, N.
    Pusztai, A.
    Vegh, E.
    Horvath, A.
    Szanto, S.
    Szucs, G.
    Hamar, A.
    Domjan, A.
    Hodosi, K.
    Seres, I.
    Kerekesa, G.
    Szekanecz, Z.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1359 - 1360
  • [27] Pharmacological strategies for mitigating anti-TNF biologic immunogenicity in rheumatoid arthritis patients
    Fernandez, Christian A.
    CURRENT OPINION IN PHARMACOLOGY, 2023, 68
  • [28] Polyneuropathy associated with anti-TNF therapy in patients with rheumatoid arthritis
    Jurand, J
    Zochodne, D
    Barr, S
    Voll, C
    Martin, L
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1405 - 1405
  • [29] THE INFLUENCE OF ANTI-TNF DRUGS ON OSTEOPOROSIS IN PATIENTS WITH RHEUMATOID ARTHRITIS
    Ruci, D.
    Ruci, V.
    Jordhani, M.
    OSTEOPOROSIS INTERNATIONAL, 2021, 32 (SUPPL 1) : S122 - S122
  • [30] CLINICAL EFFICACY TO A SECOND ANTI-TNF THERAPY IS ASSOCIATED WITH THE DEVELOPMENT OF ANTIBODIES AGAINST THE FIRST ANTI-TNF THERAPY IN PATIENTS WITH SPONDYLOARTRHITIS
    Garcia Carazo, S.
    Plasencia, C.
    Pascual Salcedo, D.
    Bonilla Hernan, G.
    Lojo, L.
    Villalba, A.
    Nuno, L.
    del Olmo, L.
    Gil Barato, S.
    Alcocer Amores, P.
    Arribas, F.
    Perez, E.
    Martin Mola, E.
    Balsa, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 250 - 251
12345